These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18590169)

  • 1. [Prognostic value of leukocytic migratory activity indices in patients with erysipelas].
    iudina IuV; Belaia OF
    Klin Lab Diagn; 2008 May; (5):47-9. PubMed ID: 18590169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [T-cell responsiveness to specific group A streptococcus antigens in patients with primary erysipelas].
    Iudina IuV; Belaia OF; Pak SG
    Klin Lab Diagn; 2007 Nov; (11):41-4. PubMed ID: 18225491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [T-cell responsiveness to specific group A streptococcus antigens in patients with recurrent erysipelas].
    Iudina IuV; Belaia OF; Pak SG; Erovichenkov AA
    Klin Lab Diagn; 2008 Apr; (4):14-8. PubMed ID: 18619201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Persistence of the L forms of hemolytic Streptococcus group A in patients with recurrent erysipelas].
    Gavrilova GA; Gorina LG; Goncharova SA; Cherkasov VL
    Vestn Akad Med Nauk SSSR; 1985; (3):13-7. PubMed ID: 3887793
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of chronic recurrent erysipelas with streptococcal vaccine].
    Haustein UF; Biella U; Tausch I; Knöll H
    Hautarzt; 1989 Apr; 40(4):215-21. PubMed ID: 2659550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of antibodies against ribosomes and various cell wall components and detection of circulating antigens of group A Streptococcus in patients with erysipelas].
    Shikhman AR; Anokhina GI; Cherkasov VL; Nikolaeva LV; Savel'ev EP
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Dec; (12):91-5. PubMed ID: 3548176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte migration test in recurrent erysipelas.
    Dobozy A; Schneider I; Hunyadi J; Simon N
    Acta Derm Venereol; 1973; 53(1):35-8. PubMed ID: 4120805
    [No Abstract]   [Full Text] [Related]  

  • 8. [The pathogenetic and prognostic significance of the level of class-E immunoglobulins in erysipelas].
    Ambalov IuM; Kovalenko AP; Usatkin AV; Khomchenko LN
    Vrach Delo; 1991 Sep; (9):76-9. PubMed ID: 1759439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibodies to type antigens of group A streptococcal cell walls in erysipelas patients].
    Cherkasov VL; Chistenkov NA
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Mar; 0(3):68-73. PubMed ID: 1092110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The diagnostic and prognostic significance of the level of circulating immune complexes in patients with recurrent erysipelas].
    Frolov VM; Boĭchenko PK; Peresadin NA
    Vrach Delo; 1990 Jun; (6):116-8. PubMed ID: 2399704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Free and bound antigen of Streptococcus group A L forms and the circulating immune complex level of erysipelas patients].
    Gorina LG; Kagan GIa; Gavrilova GA; Goncharova SA; Cherkasov VL
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Sep; (9):106-9. PubMed ID: 6195846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ["Uptake" immunoenzyme analysis for the determination of unscreened antigenic determinants of Streptococcus pyogenes group-specific A polysaccharide within the circulating immune complexes of erysipelas patients].
    Shikhman AR; Anokhina GI; Cherkasov VL; Briko NI
    Lab Delo; 1988; (4):64-6. PubMed ID: 2457748
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical significance of detecting discrete antigens of group A Streptococcus and their antibodies in the blood of erysipelas patients].
    Cherkasov VL; Anokhina GI; Shikhman AR; Briko NI
    Klin Med (Mosk); 1995; 73(4):97-8. PubMed ID: 7474846
    [No Abstract]   [Full Text] [Related]  

  • 14. [Time course of changes in serum cytokine levels and the erysipelas clinical pattern].
    Zhukova LI; Kovtun EA; Manaeva DA; Kulbuzheva MI
    Klin Lab Diagn; 2010 Feb; (2):39-42. PubMed ID: 20397578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibodies reacting with epithelial cells of the thymus and skin in the sera of patients with rheumatism and erysipelas].
    Ryzhikova EA; Spirina GV; Cherkasov VL; Guseva NG; Liampert IM
    Vestn Akad Med Nauk SSSR; 1986; (7):45-9. PubMed ID: 3529692
    [No Abstract]   [Full Text] [Related]  

  • 16. [Haptoglobin type, serum concentration of haptoglobin and agglutinating titre against T4-antigen of Streptococcus pyogenes in erysipelas (author's transl)].
    Göring HD; Köhler W; Prokop O; Bergmann R
    Dermatol Monatsschr; 1981 Aug; 167(8):492-6. PubMed ID: 7049773
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prognostic importance of determining the nonspecific resistance and allergy indices in erysipelas].
    Kriukova SA
    Vrach Delo; 1980 Apr; (4):107-9. PubMed ID: 6247841
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of Streptococcus pyogenes in the etiology of Erysipelas.
    el Tayeb SH; el Soliman AA; el Sehrawy AS
    Adv Exp Med Biol; 1997; 418():95-7. PubMed ID: 9331608
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical and pathogenetic significance of infection of erysipelas patients with the L forms of group A hemolytic Streptococcus].
    Cherkasov VL; Gavrilova GA; Gorina LG; Goncharova SA
    Klin Med (Mosk); 1986 Mar; 64(3):51-4. PubMed ID: 3520139
    [No Abstract]   [Full Text] [Related]  

  • 20. [The use of clinical, immunogenetic and immunological indices for predicting the development of the recurrent form of erysipelas of the lower limbs].
    Ambalov IuM; Levina LD; Kovalenko AP
    Lik Sprava; 1992 Sep; (9):60-5. PubMed ID: 1481508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.